Table 6.
Outcome by Polymorphism | Analyses |
|||
---|---|---|---|---|
Comparison | HR | 95% CI | P | |
ABCB1 3425 | ||||
Overall survival | Com v Het/Var (CC v CT/TT) | 1.09 | 0.71 to 1.67 | .69 |
PFS | 1.04 | 0.70 to 1.56 | .82 | |
Response | 0.97 | 0.39 to 2.38 | 1.00 | |
Neutropenia | 0.54 | 0.22 to 1.30 | .19 | |
CYP2C8 R139K | ||||
Overall survival | Com v Het/Var (GG v GA/AA) | 1.09 | 0.61 to 1.96 | .76 |
PFS | 1.12 | 0.63 to 2.00 | .69 | |
Response | 1.92 | 0.46 to 11.11 | .51 | |
Neutropenia | 1.30 | 0.35 to 5.00 | .87 | |
CYP3A4*1B | ||||
Overall survival | Com v Het/Var (AA v AG/GG) | 0.74 | 0.32 to 1.72 | .48 |
PFS | 0.36 | 0.14 to 0.94 | .04 | |
Response | 0.63 | 0.10 to 4.76 | .84 | |
Neutropenia | 0.44 | 0.04 to 2.94 | .58 | |
CYP3A5*3C | ||||
Overall survival | Com/Het v Var (AA/AG v GG) | 1.64 | 0.95 to 2.86 | .07 |
PFS | 1.56 | 0.93 to 2.63 | .09 | |
Response | 1.61 | 0.53 to 4.76 | .47 | |
Neutropenia | 1.30 | 0.44 to 3.85 | .78 | |
ERCC1 (118) | ||||
Overall survival | TT v TC/CC | 1.20 | 0.74 to 1.96 | .45 |
PFS | 1.11 | 0.69 to 1.82 | .65 | |
Response | 1.45 | 0.48 to 4.17 | .61 | |
Neutropenia | 0.57 | 0.20 to 1.61 | .35 | |
ERCC2 K751Q | ||||
Overall survival | Com v Het/Var (AA v AC/CC) | 0.97 | 0.63 to 1.49 | .89 |
PFS | 0.85 | 0.55 to 1.30 | .45 | |
Response | 0.33 | 0.13 to 0.83 | .02 | |
Neutropenia | 0.75 | 0.30 to 1.85 | .63 | |
nr1I2-206 del | ||||
Overall survival | Com v Het/Var 206 deletion | 0.82 | 0.53 to 1.25 | .35 |
PFS | 0.93 | 0.63 to 1.39 | .75 | |
Response | 0.82 | 0.34 to 2.00 | .77 | |
Neutropenia | 0.88 | 0.37 to 2.08 | .90 |
Abbreviations: HR, hazard ratio; PFS, progression-free survival; Com, common allele; Het, heterozygous allele; Var, variant allele.